# Patient Reported Outcomes in Renal Transplant Patients Tolerating Gastrointestinal (GI) Symptoms Converted to Myfortic (EC-MPS)

> **NCT00676221** · PHASE4 · UNKNOWN · sponsor: **Foothills Medical Centre** · enrollment: 110 (estimated)

## Conditions studied

- Kidney Transplant

## Interventions

- **DRUG:** Myfortic

## Key facts

- **NCT ID:** NCT00676221
- **Lead sponsor:** Foothills Medical Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-07
- **Primary completion:** 2008-08
- **Final completion:** 2008-09
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2008-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00676221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00676221, "Patient Reported Outcomes in Renal Transplant Patients Tolerating Gastrointestinal (GI) Symptoms Converted to Myfortic (EC-MPS)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00676221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*